paraquat has been researched along with digoxin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Agishi, T; Honda, H; Kobayashi, M; Ota, K; Teraoka, S; Yamagata, K | 1 |
| Dawson, AH; Whyte, IM | 1 |
| Bai, J; Chen, Y; Fan, X; Hu, J; Hu, M; Jin, J; Li, Y; Wang, B; Wang, X; Zhang, D; Zhao, S; Zou, X | 1 |
1 review(s) available for paraquat and digoxin
| Article | Year |
|---|---|
Therapeutic drug monitoring in drug overdose.
Topics: Acetaminophen; Anticonvulsants; Digoxin; Drug Monitoring; Drug Overdose; Ethanol; Ethylene Glycol; Humans; Iron; Lithium; Methanol; Paraquat; Prognosis; Salicylates; Theophylline | 1999 |
5 other study(ies) available for paraquat and digoxin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Normothermic whole body rinse-out utilizing perfluorochemical(PFC)-containing artificial blood.
Topics: Animals; Barbital; Blood Substitutes; Cholestasis, Extrahepatic; Digoxin; Dogs; Drug Combinations; Fluorocarbons; Hydroxyethyl Starch Derivatives; Paraquat; Plasma Exchange | 1984 |
Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Biological Transport; Cell Line, Tumor; Cell Survival; Digoxin; Dogs; Dose-Response Relationship, Drug; Flavonoids; Herb-Drug Interactions; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Paclitaxel; Paraquat; Protein Conformation; Rats, Sprague-Dawley; Structure-Activity Relationship | 2019 |